| Literature DB >> 25530779 |
Zhang Boyuan1, Chen Yang2, Cheng Ke1, Shen Xueyong1, Liu Sheng1.
Abstract
This review systematically assessed the clinical evidence for and against acupuncture as a treatment for psychological symptoms associated with opioid addiction. The database was accessed from MEDLINE and China Knowledge Resource Integrated Database. We included all randomized clinical trials published in Chinese and English regardless of their controls. Meta-analysis was performed using the RevMan software, version 5.2. We conducted a literature search of 16 databases from their inception to January 2014. Four studies from Western countries did not report any clinical gains in the treatment of psychological symptoms associated with opioid addiction. 10 of 12 studies from China have reported positive findings regarding the use of acupuncture to treat the psychological symptoms associated with opioid addiction. The methodological quality of the included studies was poor. The meta-analysis indicated that there was a significant difference between the treatment group and the control group for anxiety and depression associated with opioid addiction, although groups did not differ on opioid craving. This review and meta-analysis could not confirm that acupuncture was an effective treatment for psychological symptoms associated with opioid addiction. However, considering the potential of acupuncture demonstrated in the included studies, further rigorous randomized controlled trials with long followup are warranted.Entities:
Year: 2014 PMID: 25530779 PMCID: PMC4235186 DOI: 10.1155/2014/313549
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow diagram showing the number of studies included and excluded from the systematic review.
Summary of studies included in the review.
| Author | Number of subjects | Inclusion criteria | Intervention type | Type of control group | Study duration | Follow-up periods | Outcome measure | Results reported | Jadad score | Database |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lua and Talib 2013 [ | 97 | Dependence on opiates | AA | MMT | Two months | No | Craving | Better than AA | 3 | PubMed |
|
| ||||||||||
| Bearn et al. | 82 | DSM-IV | AA | Placebo | Four weeks | No | MCS | NS | 3 | PubMed |
|
| ||||||||||
|
Avants et al. | 82 | DSM-IV-R | AA | Sham | Eight weeks | No | ASI | NS | 4 | PubMed |
|
| ||||||||||
|
Meade et al. | 55 | Diagnosis of opioid dependence | TEAS | Sham | Four days | No | Craving | NS | 4 | PubMed |
|
| ||||||||||
| Wu et al. | 120 | CCMD-II-R | Body acupuncture | Buprenorphine | Ten days | No | Craving | Acu with opioid more better | 1 | PubMed |
|
| ||||||||||
| Song et al. | 62 | DSM-III-R | Body acupuncture | No treatment | Eight weeks | No | Anxiety scores | NSD | 2 | PubMed |
|
| ||||||||||
| Zeng et al. | 57 | DSM-III-R | Body acupuncture | MMT | Ten days | No | Anxiety | Better than control | 1 | PubMed |
|
| ||||||||||
| Mu et al. | 120 | DSM-IV | Electro acupuncture | Placebo | Ten weeks | six months | Craving scores of VAS | Better than control | 2 | PubMed |
|
| ||||||||||
| Zhang et al. | 181 | DSM-III-R | HANS | Placebo | Two weeks | No | Craving | Better than control | 1 | PubMed |
|
| ||||||||||
| Yang et al. | 40 | DSM-IV-TR | Body acupuncture | Body acupuncture | Four weeks | No | Anxiety | Better than acu control | 2 | CNKI |
|
| ||||||||||
| Hou et al. | 60 | ICD-10 | Body acupuncture | No treatment | Three weeks | No | Depression | Better than control | 2 | CNKI |
|
| ||||||||||
| Wen et al. | 220 | DSW-IV | Body acupuncture | Drug | Ten days | No | Anxiety | Better than control | 2 | CNKI |
|
| ||||||||||
| Zhan [ | 81 | DSM-IV-TR | Scalp acupuncture | Methadone | One months | No | Craving score | Better than control | 3 | CNKI |
|
| ||||||||||
| Mu et al. | 120 | DSM-IV | electro acupuncture | No treatment | Ten weeks | No | Anxiety Depression | Both Acu group better than control | 2 | CNKI |
|
| ||||||||||
| Yang et al. | 128 | DSM-III-R | Body acupuncture Drug | Drug | Twelve days | No | Anxiety | Same as the drug group | 2 | CNKI |
|
| ||||||||||
| Rong et al. | 94 | DSM-IV | Scalp and electro acupuncture | Body acupuncture | Ten days | No | Anxiety | Better than control | 3 | CNKI |
NS: not significant; AA: auricular acupuncture; HANS: Han's acupoint nerve stimulator; CCMD: Chinese Classification of Mental Disorders; DSM: The Diagnostic and Statistical Manual of Mental Disorders; VAS: visual analogue scale; ASI: Addiction severity Index; SOCRATES: the stage of Change Readiness and Treatment Eagerness Scale; TCS: Treatment Credibility Scale; MCS: the Maudsley Craving Scale; SOWS: Severity of Opiate Withdrawal Symptom Scale; NADA: National Acupuncture Detoxification Association; TEAS: transcutaneous electric acupoint stimulation; NSD: no statistical difference.
Acupuncture interventions in the included studies based on the STRICTA recommendation.
| Author | Details of needling | Treatment regimen | Practitioner background | ||||
|---|---|---|---|---|---|---|---|
| Insertion depth | Response sought | Stimulation method | Retention time | Needle type | |||
| Lua and Talib | 1–3 mm | NR | NR | 30 min | 0.25 × 12.55 mm | 3 times weekly for 2 months | Acupuncturist |
|
| |||||||
| Bearn et al. | NR | NR | NR | 30–40 min | 0.25 × 30 mm | Once each weekday for 2 weeks | Qualified acupuncturists |
|
| |||||||
| Avants et al. | 1–3 mm | NR | NR | 40 min | 0.2 × 15 mm | Once each weekday for 8 weeks | Professional acupuncturists |
|
| |||||||
| Meade et al. | NR | NR | TEAS | 30 min | NR | Once daily for 4 days | NR |
|
| |||||||
| Wu et al. | NR | De-qi response manual | Manipulated every 5 min | 30 min | NR | 1.3 times per day for 10 days | NR |
|
| |||||||
| Song et al. | 10–15 mm | De-qi response manual | Moxibustion Manipulated every 15 min | 30 min | 0.35 × 40 mm | Twice a week for 8 weeks | NR |
|
| |||||||
| Zeng et al. | NR | NR | Manipulated every 10 min | 30 min | NR | Once per day for 10 days | NR |
|
| |||||||
| Mu et al. | 15–30 min | De-qi response manual | Manipulated every 2 min and EA | 20 min | 0.32 × 50 mm | 3 times per week for 10 weeks | NR |
|
| |||||||
| Zhang et al. | — | Tolerance | HAN'S | NR | Electrode | 2.1 times per day for 15 days | NR |
|
| |||||||
| Yang et al. | NR | De-qi response manual | Point through point, manipulated every 6 min | 25 min | NR | Two sessions | NR |
|
| |||||||
| Hou et al. | NR | NR | EA | 20 min | NR | Once a day for three weekdays | NR |
|
| |||||||
| Wen et al. | 13–40 mm | De-qi response manual | manipulated every 10 min | 30 min | 0.35 × 40 mm | Once per day for 10 days | NR |
|
| |||||||
| Mu et al. | NR | NR | EA | 20 min | NR | Once every other day for 10 weeks (30 times) | NR |
|
| |||||||
| Rong et al. | 15–65 mm | De-qi response manual | EA | 20 min | 0.25 × 25 mm | Once daily for ten days | Physician |
|
| |||||||
| Yang et al. | NR | Tolerance | EA | 30 min | 0.25 × 50 mm | Once per day for 12 days | NR |
|
| |||||||
| Zhan [ | 10–30 mm | De-qi response manual | Manipulated every 10 min | 30 min | 33 mm | Six times one | NR |
NR: not reported, TEAS: transcutaneous electric acupoint stimulation, EA: electroacupuncture, HANS: Han's acupoint nerve stimulator, STRICTA: standards for reporting interventions in controlled trials of acupuncture.
Summary of main acupoints/sites selected in the reviewed studies.
| Acupoints/sites | Frequency of appearance ( | Percentage ( | Acupoints appearing in the literature |
|---|---|---|---|
| Neiguan (PC6) | 12 | 11.11 | 52, 47, 48, 50, 51, 45, 44, 43, 41, 39, 49, and 53 |
| Zusanli (ST36) | 10 | 9.26 | 52, 47, 48, 50, 51, 45, 44, 43, 41, and 39 |
| Sanyinjiao (SP6) | 8 | 7.41 | 52, 47, 50, 51, 45, 43, 41, and 39 |
| Shenmen (HT7) | 7 | 6.48 | 52, 47, 50, 51, 44, 43, and 53 |
| Hegu (LI4) | 6 | 5.56 | 52, 50, 45, 41, 39, and 49 |
| Shenmen (ear) | 4 | 3.70 | 38, 40, 50, and 37 |
| Kidney (ear) | 4 | 3.70 | 38, 40, 50, and 37 |
| Liver (ear) | 4 | 3.70 | 38, 40, 50, and 37 |
| Lung (ear) | 4 | 3.70 | 38, 40, 50, and 37 |
| Sympathetic (ear) | 4 | 3.70 | 38, 40, 50, and 37 |
| Laogong (PC8) | 4 | 3.70 | 50, 41, 39, and 53 |
| Sishencong (EX-HN1) | 3 | 2.78 | 45, 39, and 53 |
| Jiaji (EX-B2) | 3 | 1.85 | 43, 51, and 47 |
| Shenshu | 3 | 1.85 | 47, 51, and 43 |
| Taichong | 2 | 1.85 | 47 and 48 |
| Baihui (GV20/DU20) | 2 | 1.85 | 44 and 42 |
| Waiguan (SJ5) | 2 | 1.85 | 52 and 41 |
| Zhiyang (GV9) | 2 | 1.85 | 48 and 42 |
| Dazhui (GV14/DU14) | 1 | 0.93 | 42 |
| Mingmen (GV4) | 1 | 1.85 | 42 |
| Shendao (GV11) | 1 | 0.93 | 42 |
| Lingtai (GV10) | 1 | 0.93 | 42 |
| Shenting | 1 | 0.93 | 53 |
| Naokong | 1 | 0.93 | 53 |
| Yintang | 1 | 0.93 | 53 |
| Yangbai | 1 | 0.93 | 53 |
| Yongquan | 1 | 0.93 | 53 |
| Quanzhong | 1 | 0.93 | 53 |
| Naohu | 1 | 0.93 | 53 |
| Ben Shen | 1 | 0.93 | 53 |
| Fengchi | 1 | 0.93 | 48 |
| Anmian | 1 | 0.93 | 48 |
Figure 2Meta-analysis of acupuncture for opioid craving.
Figure 3Meta-analysis of acupuncture for anxiety associated with opioid addiction.
Figure 4Meta-analysis of acupuncture for depression associated with opioid addiction.